PMDA drug package insert
サブロン顆粒
PMDA OTC drug · 日本薬品株式会社 · package insert Mar 31, 2020
Key facts
| Brand names | サブロン顆粒 |
|---|---|
| Companies | 製造販売元／日本薬品株式会社 |
| Product type | OTC drug |
| OTC risk class | 第「２」類医薬品 |
| OTC dosage form | 散剤 |
| OTC effect category | 解熱鎮痛薬 |
| Package insert date | Mar 31, 2020 |
| PMDA document key | 530370_J0601001177 |
| PMDA company code | 530370 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: